154 related articles for article (PubMed ID: 35076344)
21. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
22. Delusional Infestation: State of the Art.
Vulink NC
Acta Derm Venereol; 2016 Aug; 96(217):58-63. PubMed ID: 27282746
[TBL] [Abstract][Full Text] [Related]
23. Intraoral Morgellons disease or delusional parasitosis: a first case report.
Dovigi AJ
Am J Dermatopathol; 2010 Aug; 32(6):603-5. PubMed ID: 20489569
[TBL] [Abstract][Full Text] [Related]
24. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
Correll CU; Manu P; Olshanskiy V; Napolitano B; Kane JM; Malhotra AK
JAMA; 2009 Oct; 302(16):1765-73. PubMed ID: 19861668
[TBL] [Abstract][Full Text] [Related]
25. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Hooshmand F; Miller S; Dore J; Wang PW; Hill SJ; Portillo N; Ketter TA
J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
[TBL] [Abstract][Full Text] [Related]
26. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
27. Management of Morgellons Disease With Low-Dose Trifluoperazine.
Yan BY; Jorizzo JL
JAMA Dermatol; 2018 Feb; 154(2):216-218. PubMed ID: 29322188
[TBL] [Abstract][Full Text] [Related]
28. Treatments for Primary Delusional Infestation: Systematic Review.
Lu JD; Gotesman RD; Varghese S; Fleming P; Lynde CW
JMIR Dermatol; 2022 Mar; 5(1):e34323. PubMed ID: 37632851
[TBL] [Abstract][Full Text] [Related]
29. Pimozide at least as safe and perhaps more effective than olanzapine for treatment of Morgellons disease.
Koblenzer CS
Arch Dermatol; 2006 Oct; 142(10):1364. PubMed ID: 17043201
[No Abstract] [Full Text] [Related]
30. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
[TBL] [Abstract][Full Text] [Related]
31. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness and Price of Aripiprazole for Schizophrenia in the Brazilian Public Health System.
Soares Santos A; de Souza Noronha KVM; Viegas Andrade M; Mariano Ruas C
J Ment Health Policy Econ; 2020 Mar; 23(1):27-37. PubMed ID: 32458815
[TBL] [Abstract][Full Text] [Related]
33. Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.
Buckley PF
Drugs Today (Barc); 2005 Jan; 41(1):5-11. PubMed ID: 15753965
[TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.
Edwards NC; Locklear JC; Rupnow MF; Diamond RJ
Pharmacoeconomics; 2005; 23 Suppl 1():75-89. PubMed ID: 16416763
[TBL] [Abstract][Full Text] [Related]
35. The Koo-Brownstone staging system as a tool to assist in the management of patients with a possible diagnosis of dermatological delusions: an experts suggestion.
Brownstone N; Koo J
J Dermatolog Treat; 2022 Dec; 33(8):3199-3201. PubMed ID: 35950783
[TBL] [Abstract][Full Text] [Related]
36. Nature and treatment of delusional parasitosis: a different experience in India.
Srinivasan TN; Suresh TR; Jayaram V; Fernandez MP
Int J Dermatol; 1994 Dec; 33(12):851-5. PubMed ID: 7883408
[TBL] [Abstract][Full Text] [Related]
37. Formication, tactile hallucinations, delusional parasitosis, and Morgellons: Enough to make your skin crawl.
Dowben JS; Kowalski PC; Keltner NL
Perspect Psychiatr Care; 2017 Oct; 53(4):220-221. PubMed ID: 28960311
[No Abstract] [Full Text] [Related]
38. Variable clinical presentations of secondary delusional infestation: an experience of six cases from a psychodermatology clinic.
Altunay IK; Ates B; Mercan S; Demirci GT; Kayaoglu S
Int J Psychiatry Med; 2012; 44(4):335-50. PubMed ID: 23885516
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Oral Mucosal Lesions Associated With Overlapping Psychodermatologic Disorders.
Alfaris S; France K; Sollecito TP; Stoopler ET
Compend Contin Educ Dent; 2018 Apr; 39(4):244-1246. PubMed ID: 29600872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
